<DOC>
	<DOCNO>NCT02593474</DOCNO>
	<brief_summary>The purpose open-label pilot study determine tolerability applicability outpatient long-acting injectable naltrexone ( Vivitrol ) treatment individual age 16-21 ( `` old youth '' ) opioid use disorder . Outpatient treatment consist 7-day outpatient detoxification / naltrexone induction procedure follow 8-weeks treatment Vivitrol .</brief_summary>
	<brief_title>Medication-Assisted Treatment Youth With Substance Use Disorders</brief_title>
	<detailed_description>The rate opioid use youth rise . Long-acting injectable naltrexone ( Vivitrol ) , medication block effect opioid drug , show effective treatment opioid dependence adult . Vivitrol important option individual want agonist treatment ( e.g . buprenorphine , methadone ) . Vivitrol may particularly appeal youth difficulty reach opioid use goal daily oral medication monthly injection therefore eliminate problem daily medication non-adherence . Vivitrol may also appeal family reduce conflict around issue adherence thus support positive parenting . Whereas Vivitrol use clinically minor , study prospective outpatient trial . Starting naltrexone , however , challenge opioid-dependent individual detoxification require prior treatment medication.There standard outpatient detoxification protocol opioid-dependent youth . Therefore , study need support broader approve use Vivitrol population . The purpose open-label pilot study determine tolerability applicability outpatient long-acting injectable naltrexone ( Vivitrol ) treatment individual age 16-21 ( `` old youth '' ) opioid use disorder . We aim 16 old youth complete trial . Participants undergo outpatient detoxification / induction procedure hone past 13 year work medication others Division currently use safely opioid-dependent adult ongoing clinical trial . The detoxification / induction procedure consist single day buprenorphine follow washout day 4 day ascend oral naltrexone dose prior administer dose injectable naltrexone , typically Day 8 . Participants receive additional Vivitrol injection 4 week first ; also receive weekly medication management therapy research psychiatrist . Following 9 week trial , participant eligible additional third injection follow 4 week therapy proper follow-up treatment arrange . Primary Aim : To determine tolerability applicability outpatient Vivitrol treatment individual age 16-21 ( `` old youth '' ) opioid use disorder determine retention treatment across study . Outpatient treatment consist 7-day detoxification / naltrexone induction procedure follow 8-weeks treatment Vivitrol . Secondary Aim 1 : To determine tolerability 7-day outpatient detoxification / naltrexone induction old youth assess retention first administration Vivitrol . Secondary Aim 2 : To determine tolerability initial ( 4-week ) treatment Vivitrol assess receipt second Vivitrol injection week 4 . Secondary Aim 3 : To determine safety tolerability Vivitrol treatment assess measure adverse event .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Males female 1621 year age If adult participant ( &gt; 18 y/o ) , capacity provide inform consent If minor participant ( &lt; 18 y/o ) , capacity assent If minor participant ( &lt; 18 y/o ) , legal guardian available give inform consent accompany minor participant appointment formally designate another responsible adult accompany minor participant appointment subsequent initial visit . DSM5 criterion opioid use disorder primary diagnosis Psychiatrically stable Physically healthy Voluntarily seek outpatient opioid antagonist treatment Able perform study procedure English speak History allergy intolerance hypersensitivity study medication Meets DSM5 criterion substance use disorder opioid use disorder primary diagnosis ( except nicotine caffeine ) Comorbid psychiatric disorder might interfere make participation hazardous , include DSM5 diagnosis psychotic disorder , severe major depressive disorder , psychiatric disorder may , accord investigator 's judgment , require either pharmacological nonpharmacological intervention course study Pregnancy , lactation within last 6 month , failure use effective contraceptive method ( condom , diaphragm , birth control pill , IUD ) sexually active female Methadone maintenance treatment regular use illicit methadone ( &gt; 30 mg per week ) Maintenance , regular use , buprenorphine longacting opioid agonist Current suicide risk suicide attempt within past year Unstable medical condition laboratory test data , might make participation hazardous , acute hepatitis ALT AST &gt; 3 time normal History accidental drug overdose last three year define episode opioidinduced unconsciousness incapacitation , whether medical treatment seek receive Painful medical condition require ongoing opioid analgesia anticipate surgery necessitate opioid medication</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>Youth</keyword>
</DOC>